Triple agonist (GIP, GLP-1, glucagon).
Adds glucagon receptor activity to the GLP-1/GIP profile, driving thermogenesis on top of appetite suppression.
Use
Aggressive metabolic recomposition. Severe insulin resistance. Advanced obesity.
Route
Subcutaneous injection, weekly.
Pairs with
Strength training. Sermorelin or Ipamorelin/CJC-1295 nightly.
Status
Investigational. Late-stage trials.